| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Minerva Neurosciences, Inc. (NERV) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 16 sells. NERV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.25M | $13.48M | - | |
| Pres | 1.50M | $8.98M | - | |
| CFO | 500.0K | $3.00M | - | |
| Dir | 364.5K | $2.18M | - | |
| Dir | 50.0K | $299.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2019 | Index Venture Associates III Ltd | 10% Owner | Sell | 197,000 | $6.01 | $1,184,836.80 | -4.8% | |
| Jun 20, 2019 | Index Venture Associates III Ltd | 10% Owner | Sell | 110,818 | $4.41 | $488,911.18 | -1.3% | |
| Jun 18, 2019 | Index Venture Associates III Ltd | 10% Owner | Sell | 105,918 | $4.44 | $470,730.46 | -1.2% | |
| Jun 14, 2019 | Index Venture Associates III Ltd | 10% Owner | Sell | 78,467 | $4.51 | $353,737.37 | -0.9% | |
| Jun 12, 2019 | Index Venture Associates III Ltd | 10% Owner | Sell | 60,051 | $4.69 | $281,342.92 | -0.7% | |
| May 20, 2019 | Index Venture Associates III Ltd | 10% Owner | Sell | 22,918 | $6.02 | $137,895.58 | -0.3% | |
| May 16, 2019 | Index Venture Associates III Ltd | 10% Owner | Sell | 134,828 | $6.66 | $898,160.65 | -1.0% | |
| Dec 20, 2018 | Doyle William F53 | Director | Buy | 2,000 | $6.50 | $13,000.00 | +9.7% | |
| Dec 17, 2018 | Race Geoff | EVP, CFO &Cbo | Sale+OE | 5,999 | $7.46 | $44,752.54 | -2.9% | |
| Dec 17, 2018 | Ahlholm Frederick W | SVP, Chief Accounting Officer | Sale+OE | 1,559 | $7.46 | $11,630.14 | -11.7% |